2014
Low Adherence to Helicobacter pylori Testing in Hospitalized Patients with Bleeding Peptic Ulcer Disease
Kim JJ, Lee JS, Olafsson S, Laine L. Low Adherence to Helicobacter pylori Testing in Hospitalized Patients with Bleeding Peptic Ulcer Disease. Helicobacter 2014, 19: 98-104. PMID: 24617668, DOI: 10.1111/hel.12114.Peer-Reviewed Original ResearchConceptsH. pylori testingProportion of patientsIndex hospitalizationHospitalized patientsConsecutive hospitalized patientsPeptic ulcer diseaseHelicobacter pylori testingInitial endoscopyUlcer diseaseSerologic testingSingle centerEndoscopy databaseSociety guidelinesGastric ulcerLow adherencePatientsUlcersMultivariate analysisHelicobacter pyloriHospitalizationDirect testingBiopsyTestingEndoscopyPylori
2001
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.
Laine L, Schoenfeld P, Fennerty M. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Annals Of Internal Medicine 2001, 134: 361-9. PMID: 11242496, DOI: 10.7326/0003-4819-134-5-200103060-00008.Peer-Reviewed Original ResearchConceptsH. pylori eradication therapyNonulcer dyspepsiaPylori eradication therapyEradication therapyControl therapyOdds ratioH. pyloriHelicobacter pyloriDefinition of dyspepsiaDuplicate data extractionEnd of therapyH. pylori infectionAnalysis of trialsPylori infectionCombination therapyMethodologic qualityTreatment successDyspepsiaPersistent infectionReference listsTherapyPatientsStudy designPrimary investigatorPylori
2000
Influence of H. pylori and other potential risk factors on clinical gi events in a double-blind outcome study of rofecoxib VS. Naproxen
Laine L, Bombardier C, Hawkey C, Shapiro D, Reicin A. Influence of H. pylori and other potential risk factors on clinical gi events in a double-blind outcome study of rofecoxib VS. Naproxen. Gastroenterology 2000, 118: a862. DOI: 10.1016/s0016-5085(00)85588-2.Peer-Reviewed Original Research
1998
Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori.
Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Annals Of Internal Medicine 1998, 129: 547-50. PMID: 9758575, DOI: 10.7326/0003-4819-129-7-199810010-00007.Peer-Reviewed Original ResearchConceptsUrea breath testProton pump inhibitor therapyBreath test resultsProton pump inhibitorsBreath testInhibitor therapyH. pyloriDiagnostic testingCompletion of therapyProportion of patientsNegative breath test resultH. pylori infectionUrea breath test resultsLansoprazole therapyFalse-negative resultsGastroenterology clinicPylori infectionPatientsHelicobacter pyloriTherapyDuration of conversionPyloriPositive resultsLansoprazoleDaysReduced risk of clarithromycin-resistant H. pylori with amoxicillin cotherapy: Results from 3 multicenter double-blind U.S. trials
Laine L, Suchower L, Connors A, Frantz J, Neil G. Reduced risk of clarithromycin-resistant H. pylori with amoxicillin cotherapy: Results from 3 multicenter double-blind U.S. trials. Gastroenterology 1998, 114: a193. DOI: 10.1016/s0016-5085(98)80786-5.Peer-Reviewed Original ResearchHelicobacter pylori and peptic ulcer disease
Laine L, Fendrick A. Helicobacter pylori and peptic ulcer disease. Postgraduate Medicine 1998, 103: 231-243. PMID: 9519040, DOI: 10.3810/pgm.1998.03.423.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPeptic ulcer diseaseUlcer diseaseAppropriate antimicrobial therapyPrimary care physiciansCost of careEffective regimensCare physiciansClinical outcomesH pyloriSuccessful treatmentAntimicrobial therapyPatient complianceHelicobacter pyloriImportance of identifyingDiseaseInfectionPyloriTreatmentRegimenRegimensPatientsTherapyPhysiciansCare
1995
Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers
Laine L, Cohen H, Sloane R, Marin-Sorensen M, Weinstein W. Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointestinal Endoscopy 1995, 42: 420-423. PMID: 8566631, DOI: 10.1016/s0016-5107(95)70043-9.Peer-Reviewed Original ResearchConceptsAntral nodularityPositive predictive valueH. pyloriPredictive valueArea gastricaeEndoscopic findingsEndoscopic featuresInterobserver agreementDiagnostic valueH. pylori gastritisSpecific endoscopic featuresGastric bodyHistologic gastritisPylori gastritisBiopsy specimensHealthy subjectsGastritisNormal volunteersHelicobacter pyloriFull endoscopyPyloriNodularityReproducible findingsErythema
1993
HELICOBACTER PYLORI, GASTRIC ULCER, AND AGENTS NOXIOUS TO THE GASTRIC MUCOSA
Laine L. HELICOBACTER PYLORI, GASTRIC ULCER, AND AGENTS NOXIOUS TO THE GASTRIC MUCOSA. Gastroenterology Clinics Of North America 1993, 22: 117-125. PMID: 8449561, DOI: 10.1016/s0889-8553(21)00267-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsH. pylori prevalenceGastric ulcerHistologic gastritisH. pyloriGastric injuryPylori prevalenceDuodenal ulcerGastric mucosaNoxious agentsInflammatory cell infiltrateH. pylori infectionNSAID usersCell infiltratePylori infectionDuodenal contentsNSAIDsUlcersGross injuryGastritisPatientsHelicobacter pyloriPyloriInjuryMucosaPrevalence
1989
Campylobacter pylori in alcoholic hemorrhagic “gastritis”
Laine L, Marin-Sorensen M, Weinstein W. Campylobacter pylori in alcoholic hemorrhagic “gastritis”. Digestive Diseases And Sciences 1989, 34: 677-680. PMID: 2785447, DOI: 10.1007/bf01540337.Peer-Reviewed Original ResearchConceptsSubepithelial hemorrhageCampylobacter pyloriInflammatory cell scoresInflammatory cell densityMucosal hemorrhageEdema scoreAlcoholic patientsHistologic abnormalitiesMononuclear cellsBiopsy specimensEpithelial abnormalitiesHemorrhagic lesionsNeutrophil scoreHemorrhage scoreHistologic scoringHemorrhageMucosaBiopsyBiopsy slidesMean scoreScoresPresence of CPPyloriAbnormalitiesCell density